|
|
|
|
|
|
|
As a NARFE member, you understand the importance of investing in research to advance the fight against Alzheimer's disease, and this month brings another in a series of policy victories. Together with NARFE member support, the Alzheimer's Association will continue to work with Congress to ensure continued bipartisan support for urgently needed research funding increases. Thank you, NARFE members and leaders, for your dedication to this cause.
|
|
|
Call to Congress answered with funding gains at National Institutes of Health
On May 5, a $400 million increase in Alzheimer's research funding was signed into law, increasing federal funding at the National Institutes of Health (NIH) to nearly $1.4 billion. After years of stagnant funding, this is the second year in a row the Alzheimer's Association's request for historic funding increases has been acted on by our federal leaders. Read more.
|
|
|
|
|
Bryotatin-1 Phase II clinical trial results show promise
Neurotrope announced topline results of a phase II clinical trial of the investigational therapy Bryostatin-1 in people with moderate to severe Alzheimer's disease. There was a trend toward improvement in memory, thinking and behavior, but this study is not big enough or long enough to show with certainty whether or not this is an effective treatment. The only way to continue the discovery of new approaches and treatment targets for Alzheimer's is through a greater investment in research.
|
|
|
|
|
Palliative Care and Hospice Education and Training Act (PCHETA) reintroduced
The Palliative Care and Hospice Education and Training Act (PCHETA) has been reintroduced by Sen. Tammy Baldwin (D-Wisc.), Sen. Shelley Moore Capito (R-W.Va.), Rep. Eliot Engel (D-N.Y.) and Rep. Tom Reed (R-NY). PCHETA would ensure an adequate, well-trained palliative care workforce through workforce training, education and awareness, and enhanced research. In addition, the legislation is consistent with recommendations made by the Advisory Council on Alzheimer's Care, Research and Services. Read more.
|
|
|
|
|
What you need to know about at-home genetic testing
Perhaps your grandmother had Alzheimer's, or maybe your mom or dad is currently living with the disease. You may be concerned that you're seeing signs of the disease in yourself. It's natural to be curious if a genetic test is valuable in predicting the likelihood of developing Alzheimer's. Keith Fargo, Ph.D., Alzheimer's Association Director of Scientific Programs and Outreach, answers questions about this type of testing and what the results tell (and don't tell) you. Read more.
|
|
|
|
|
Join Our Mailing List
|
|
|
|
|
NARFE Contributions to Advance Alzheimer's Research
NARFE 2018 GOAL $13 MILLION
|
|
|
|
24/7 Helpline: 1-800-272-3900
|
|
